Chronic hepatitis C virus infections in Brazilian patients: Association with genotypes, clinical parameters and response to long term alpha interferon therapy

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 41, Issue 3, 1999, Pages 183-189

  Bassit, Leda ^b   Da Silva, Luiz C ^a   Ribeiro Dos Santos, Gabriela ^c   Maertens, Geert ^c   Carrilho, Flair J ^a   Fonseca, Luis E P ^a   Alves, Venâncio A F ^c   Gayotto, Luis C C ^c   Pereira, Analice N ^c   Takei, Kioko ^c   Chamone, Dalton ^c   Sáez Alquézar, Amadeo ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^c NONE

Author keywords

Brazilian patients; Genotypes; HCV; IFN therapy; Sustained response

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHILD; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE;

EID: 0032786804     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651999000300010     Document Type: Article

References (41)

1. ALTER, A.J.; PURCELL, R.H.; SHIH, J.W. et al. - Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New Engl.J. Med., 321: 1494-1500, 1089.
2. ALTMAN, D.G - Practical statistics for medical research. London, Chapman & Hall, 1995. p. 253-257.
3. BASSIT, L.; RIBEIRO-DOS-SANTOS, G.; DA SILVA, L.C. et al. - Genotype distribution of hepatitis C virus in São Paulo, Brazil: rare subtype found. Hepatology, 29: 994-995, 1999.
4. BENVEGNÙ, L.; PONTISSO, P.; CAVALLETTO, D. et al. - Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology, 25: 211-215, 1997.
5. BRUNO, S.; SILINI, E.; CROSIGNANI, A. et al - Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology, 25: 754-758, 1997.
6. CHAN, S.-W.; MCOMISH, F.; HOLMES, E.C. et al. - Analysis of a new hepatitis C viras type and its phylogenetic relationship to existing variants. J. gen. Virol., 73: 1131-1141, 1992.
7. CHEMELLO, L.; CAVALLETTO, L.; BERNARDINELLO, E. et al. - The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J. Hepat., 23 (suppl.): 8-12, 1995.
8. CHOO, Q.-L.; KUO, G.; WEINER, A.J. et al. - Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244: 359-362, 1989.
9. CHOO, Q.-L.; RICHMAN, K.H.; HAN, J.H. et al. - Genetic organization and diversity of the hepatitis C virus. Proc. nat. Acad. Sci. (Wash.), 88: 2451-2455, 1991.
10. DEMEDINA, M. & SCHIFF, E.R. - Hepatitis C: diagnostic assays. Semin. Liver Dis., 15: 33-39, 1995.
11. DESMET, V.J.; GERBER, M.; HOOFNAGLE, J.H.; MANNS, M. & SCHEUER, P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology, 19: 1513-1520, 1994.
12. DI BISCEGLIE, A.M.; GOODMAN, Z.D.; ISHAK, K.G. et al. - Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology, 14: 969-974, 1991.
13. FEUCHT, H.-H.; SCHRÖTER, M.; ZÖLLNER, B. et al. - The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b. J. infect. Dis., 175: 685-688, 1997.
14. FLEISS, J.L. - Statistical methods for rates and proportions. 2.ed. New York, John Wiley, 1981. p.321.
15. GARSON, J.A.; BRILLANTI, S.; WHITBY, K. et al. - Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J. med. Virol., 45: 348-353, 1995.
16. HOOFNAGLE, J.H. & DI BISCEGLIE, A.M. - The treatment of chronic viral hepatitis. New Engl. J. Med., 336: 347-356, 1997.
17. HOPF, U.; BERG, T.; KÖNIG, V. et al. - Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. J. Hepat., 24 (suppl. 2): 67-73, 1996.
18. JOUËT, P.; ROUDOT-THORAVAL, F.; DHUMEAUX, D. & METREAU, J.M. Comparative efficacy of interferon alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology, 106: 686-690, 1994.
19. KLETER, B.; BROUWER, J.T.; NEVENS, F. et al. - Hepatitis C viras genotypes: epidetmiological and clinical associations. Liver, 18: 32-38, 1998.
20. KUO, G.; CHOO, Q.-L.; ALTER, H.J. et al. - An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science, 244: 362-364, 1989.
21. LAU, J.Y.N.; DAVIS, G.L.; PRESCOTT, L.E. et al. - Distribution of hepatitis C viras genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann. intern. Med., 124: 868-876, 1996.
22. LE GUEN, B.; SQUADRITO, G.; NALPAS, B. et al. - Hepatitis C viras genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology, 25: 1250-1257, 1997.
23. LINDSAY, K.L.; DAVIS, G.L.; SCHIFF, E.R. et al. - Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Hepatology, 24: 1034-1040, 1996.
24. MAERTENS, G. & STUYVER, L. - Genotypes and genetic variation of hepatitis C viras. In: HARRISON, T.J. & ZUCKERMAN, A.J., ed. The molecular medicine of viral hepatitis. England. Wiley, 1997. p.183-233.
25. MARCELLIN, P.; BOYER, N.; MARTINOT, M. & ERLINGER, S. - Interferon therapy in hepatitis C: benefits and limitations. In: ARROYO, V.; BOSCH, J.; BRUGUERA, M. & RODÉS, J., ed. Therapy in liver diseases. The pathophysiological basis of therapy. Barcelona, A.S. Masson, 1997. p.309-316.
26. MIHM, S.; FAYYAZI, A.; HARTMANN, H. & RAMADORI, G. - Analysis of histopathological manifestations of chronic hepatitis C viras infection with respect to viras genotype. Hepatology, 25: 735-739, 1997.
27. MITA, E.; HAYASHI, N.; KANAZAWA, Y. et al. - Hepatitis C viras genotype and RNA liter in the progression of type C chronic liver disease. J. Hepat., 21: 468-473, 1994.
28. PAWLOTSKY, J.-M.; ROUDOT-THORAVAL, F.; BASTIE, A. et al. - Factors affecting treatment responses to interferon-α in chronic hepatitis C. J. infect. Dis.; 174: 1-7, 1996.
29. PAWLOTSKY, J.M.; TSAKIRIS, L.; ROUDOTTHORAVAL, F. et al. - Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J. infect. Dis., 171: 1607-1610, 1995.
30. PEIG-GINABREDA, M.G.; YOSHIDA, C.F.T. & NIEL, C. - Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b. Braz. J. med. biol. Res., 30: 339-345, 1997.
31. POYNARD, T.; BEDOSSA, P.; CHEVALLIER. M. et al. - A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. New Eng. J. Med., 332: 1457-1462, 1995.
32. REICHARD, O.; NORKRANS, G.; FRYDEN, A. et al. - Randomized, double-blind, placebo-controlled trial of interferon alpha-2b with or without ribavirin for chronic hepatitis C. The Swedish study group. Lancet, 351: 83-87, 1998.
33. SCHALM, S.W.; BROUWER, J.T.; CHEMELLO, L. et al. - Interferon-ribavirin combination therapy for chronic hepatitis C. Dig. Dis. Sci., 41 (suppl.): 131S-134S, 1996.
34. SHAKIL, A.C.; CONRY-CANTINELA, C.; ALTER, H.J. et al. - Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann. intern. Med., 123: 330-337, 1995.
35. SMITH, D.B.; PATHIRANA, S.; DAVIDSON, F. et al. - The origin of hepatitis C virus genotypes. J. gen. Virol., 78: 321-328, 1997.
36. STUYVER, L.; ROSSAU, R.; WYSEUR, A. et al. - Typing of hepatilis C virus isolates and characterization of new subtypes using a line probe assay. J. gen. Virol., 74: 1093-1102, 1993.
37. STUYVER, L.; WYSEUR, A.; VANARNHEM, W.; HERNANDEZ, F.& MAERTENS, G. - Second-generation line probe assay for hepatitis C virus genotyping. J. clin. Microbiol., 34: 2259-2266, 1996.
38. YAMADA, M.; KAKUMU, S.; YOSHIOKA, K. et al. - Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig. Dis. Sci., 39: 234-239, 1994.
39. YOSHIOKA, K.; AIYAMA, T.; OKUMURA, A. et al. - Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a. J. infect. Dis., 175:505-510, 1997.
40. YUKI, N.; HAYASHI, N. & KAMADA, T. - HCV viraemia and liver injury in symptom-free blood donors. Lancet, 342: 444, 1993.
41. ZEIN, N.N.; RAKELA, J.; KRAWITT, E.L. et al. - Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity. and response to interferon therapy. Ann. intern. Mod., 125: 634-639, 1996.